Stay updated on TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial page.

Latest updates to the TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe history now shows the latest site revision as v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe additions and deletions are administrative in nature, introducing Revision: v3.4.2 and removing prior policy notices; there is no impact on study data or core page functions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedAdded a site-wide government funding notice. Updated the site revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.6%

- Check48 days agoChange DetectedUI updates include a glossary toggle and color-coded change highlights (green for additions, red for deletions) with a revised version label (v3.4.0) and a No FEAR Act Data indicator. These changes do not affect the core study content or data.SummaryDifference0.7%

- Check62 days agoChange DetectedThe page history now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page history shows the addition of Revision: v3.3.3 and the removal of Revision: v3.3.2, along with the removal of the HHS Vulnerability Disclosure link. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TSR-033 & Anti-PD-1 in Solid Tumors Clinical Trial page.